Grant: Discovery Grants Program - Individual
McMaster University
$31,000.00
Regulation and Function of Melatonin Receptors
EF 2019-20
Résumé
***The pineal gland in mammals including humans, produces a chemical messenger or hormone called melatonin, which exhibits very low daytime levels, with peak levels present in the circulation at night. This hormone plays an important role in the regulation of circadian rhythms by interacting with the biological clock in the brain. It is involved in modulating numerous other physiological activities including neuroendocrine function, immune responses and reproduction. Moreover, melatonin is a cytoprotective hormone that protects cells against the injurious effects of free radicals and environmental neurotoxins. In order to produce its diverse effects, melatonin travels in the bloodstream to reach the brain or other organs, where it binds to specific sites or receptors, which are located on its target cells. Melatonin binding conveys a signal which results in a cascade of cellular responses, with consequent changes in the function of its target cells and organs. Importantly, older individuals exhibit a significant decrease in their blood levels of this protective hormone, which is thought to be related to the progressive age-related onset of physiological dysfunction.****Our NSERC-funded studies have shown that certain drugs, which alter gene activity by an epigenetic mechanism, cause a significant upregulation or increase in the number of melatonin receptors in the brain and in cultured cells. Epigenetics involves the regulation of gene expression, without changes to the underlying DNA sequence. This research program is aimed at determining how the above mentioned drug-induced increases in melatonin receptors influences the signaling and function of melatonin in the young or aging brain. Melatonin has been shown to increase the formation of new cells in an area of the brain which is essential for cognitive function such as memory and learning. However, the progressive loss of both melatonin and its receptors results in a decrease in activity of the melatonergic system in aging mammals. Given the decline in both cognition and melatonergic activity with aging, it is anticipated that our novel strategy for increasing the number of melatonin receptors coupled with administration of this hormone, will maintain or restore cognition and other essential functions in the aging brain. In addition, this proposal is aimed at clarifying the mechanisms involved in this novel and original strategy for upregulating melatonin receptors in the brain and other target tissues. Clarification of these mechanisms and the functional correlates of melatonin receptor upregulation will be a significant advance in melatonin physiology and provide a base for understanding its diverse roles in mammalian biology. Ultimately, it should be possible to utilize this knowledge in order to preserve melatonin receptor expression and function, thus maintaining the homeostatic benefits of this hormone.******
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2016-05697
Name nom
Niles, Lennard
Department département
Psychiatry and Behavioural Neurosciences
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2016
Award amount
31000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5504
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal physiology and metabolism
Research subject fr
Physiologie et métabolisme des animaux
Installment
inst:4 - 5
Partie
4
Nb partie
5
Application title
Regulation and Function of Melatonin Receptors
Keyword
NSERC
Application summary
***The pineal gland in mammals including humans, produces a chemical messenger or hormone called melatonin, which exhibits very low daytime levels, with peak levels present in the circulation at night. This hormone plays an important role in the regulation of circadian rhythms by interacting with the biological clock in the brain. It is involved in modulating numerous other physiological activities including neuroendocrine function, immune responses and reproduction. Moreover, melatonin is a cytoprotective hormone that protects cells against the injurious effects of free radicals and environmental neurotoxins. In order to produce its diverse effects, melatonin travels in the bloodstream to reach the brain or other organs, where it binds to specific sites or receptors, which are located on its target cells. Melatonin binding conveys a signal which results in a cascade of cellular responses, with consequent changes in the function of its target cells and organs. Importantly, older individuals exhibit a significant decrease in their blood levels of this protective hormone, which is thought to be related to the progressive age-related onset of physiological dysfunction.****Our NSERC-funded studies have shown that certain drugs, which alter gene activity by an epigenetic mechanism, cause a significant upregulation or increase in the number of melatonin receptors in the brain and in cultured cells. Epigenetics involves the regulation of gene expression, without changes to the underlying DNA sequence. This research program is aimed at determining how the above mentioned drug-induced increases in melatonin receptors influences the signaling and function of melatonin in the young or aging brain. Melatonin has been shown to increase the formation of new cells in an area of the brain which is essential for cognitive function such as memory and learning. However, the progressive loss of both melatonin and its receptors results in a decrease in activity of the melatonergic system in aging mammals. Given the decline in both cognition and melatonergic activity with aging, it is anticipated that our novel strategy for increasing the number of melatonin receptors coupled with administration of this hormone, will maintain or restore cognition and other essential functions in the aging brain. In addition, this proposal is aimed at clarifying the mechanisms involved in this novel and original strategy for upregulating melatonin receptors in the brain and other target tissues. Clarification of these mechanisms and the functional correlates of melatonin receptor upregulation will be a significant advance in melatonin physiology and provide a base for understanding its diverse roles in mammalian biology. Ultimately, it should be possible to utilize this knowledge in order to preserve melatonin receptor expression and function, thus maintaining the homeostatic benefits of this hormone.******